David R. Staskin
Directeur/Membre du Conseil chez Inpellis, Inc.
Profil
David R.
Staskin is currently the Secretary, Director & Chief Strategy Officer at Inpellis, Inc. He completed his undergraduate degree at Cornell University and his doctorate at Drexel University College of Medicine.
Postes actifs de David R. Staskin
Sociétés | Poste | Début |
---|---|---|
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | Directeur/Membre du Conseil | 01/01/2015 |
Formation de David R. Staskin
Cornell University | Undergraduate Degree |
Drexel University College of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Inpellis, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing transdermal prescription therapeutics for treating acute and chronic pain resulting from musculoskeletal disorders and peripheral neuropathy. Its products include transdermal ibuprofen for moderate to severe osteoarthritis and transdermal benfotiamine for painful diabetic neuropathy. The company was founded in 2012 and is headquartered in Haddonfield, NJ. | Health Technology |